NewSquare Capital LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 264 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
NewSquare Capital LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2020$71,000
-50.0%
4,0000.0%0.01%
-50.0%
Q2 2019$142,000
+6.0%
4,0000.0%0.03%0.0%
Q1 2019$134,000
+2.3%
4,0000.0%0.03%
-7.1%
Q4 2018$131,000
-46.3%
4,0000.0%0.03%
-39.1%
Q3 2018$244,000
+25.1%
4,0000.0%0.05%
+15.0%
Q2 2018$195,000
-54.1%
4,0000.0%0.04%
-56.5%
Q1 2018$425,000
+77.8%
4,0000.0%0.09%
+67.3%
Q4 2017$239,000
+149.0%
4,0000.0%0.06%
+139.1%
Q3 2017$96,000
+23.1%
4,0000.0%0.02%
+21.1%
Q2 2017$78,000
-17.0%
4,0000.0%0.02%
-13.6%
Q1 2017$94,000
+91.8%
4,0000.0%0.02%
+83.3%
Q4 2016$49,000
-29.0%
4,0000.0%0.01%
-25.0%
Q3 2016$69,000
+21.1%
4,0000.0%0.02%
+14.3%
Q2 2016$57,000
+3.6%
4,0000.0%0.01%
-12.5%
Q1 2016$55,000
-17.9%
4,0000.0%0.02%
-15.8%
Q4 2015$67,000
+52.3%
4,0000.0%0.02%
+46.2%
Q3 2015$44,000
-12.0%
4,0000.0%0.01%
-13.3%
Q2 2015$50,000
+13.6%
4,0000.0%0.02%
+7.1%
Q1 2015$44,000
-29.0%
4,0000.0%0.01%
-33.3%
Q4 2014$62,000
+29.2%
4,0000.0%0.02%
+23.5%
Q3 2014$48,000
-5.9%
4,0000.0%0.02%
-5.6%
Q2 2014$51,000
+6.2%
4,0000.0%0.02%
-5.3%
Q1 2014$48,000
+6.7%
4,0000.0%0.02%
-13.6%
Q4 2013$45,000
+7.1%
4,0000.0%0.02%
+10.0%
Q3 2013$42,000
-8.7%
4,0000.0%0.02%
-13.0%
Q2 2013$46,0004,0000.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2020
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders